| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide mannosidase activity | 1.65e-06 | 10 | 49 | 3 | GO:0015924 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 5.27e-06 | 103 | 49 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity | 5.90e-06 | 2 | 49 | 2 | GO:0004572 | |
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 5.90e-06 | 2 | 49 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 6.19e-06 | 15 | 49 | 3 | GO:0004559 | |
| GeneOntologyMolecularFunction | mannosidase activity | 7.60e-06 | 16 | 49 | 3 | GO:0015923 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 2.69e-05 | 144 | 49 | 5 | GO:0016798 | |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 5.87e-05 | 5 | 49 | 2 | GO:0106294 | |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 3.83e-04 | 12 | 49 | 2 | GO:0016174 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 3.83e-04 | 12 | 49 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 1.09e-03 | 20 | 49 | 2 | GO:0050664 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 1.32e-03 | 22 | 49 | 2 | GO:0050321 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.21e-03 | 749 | 49 | 7 | GO:0005509 | |
| GeneOntologyBiologicalProcess | protein deglycosylation | 1.00e-05 | 18 | 49 | 3 | GO:0006517 | |
| GeneOntologyBiologicalProcess | cuticle development | 1.66e-05 | 3 | 49 | 2 | GO:0042335 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 1.88e-05 | 22 | 49 | 3 | GO:0050665 | |
| GeneOntologyBiologicalProcess | positive regulation of autophagosome maturation | 1.53e-04 | 8 | 49 | 2 | GO:1901098 | |
| GeneOntologyCellularComponent | vacuole | CALCOCO2 HSPG2 ATP6V0D1 SZT2 HYAL3 GPR137B IFI30 SPPL2B UVRAG | 2.77e-04 | 913 | 50 | 9 | GO:0005773 |
| GeneOntologyCellularComponent | lysosome | 6.27e-04 | 811 | 50 | 8 | GO:0005764 | |
| GeneOntologyCellularComponent | lytic vacuole | 6.27e-04 | 811 | 50 | 8 | GO:0000323 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 8.37e-04 | 18 | 50 | 2 | GO:0043020 | |
| Domain | DUOX1 | 7.02e-06 | 2 | 50 | 2 | IPR029595 | |
| Domain | MARK/par1 | 4.20e-05 | 4 | 50 | 2 | IPR033624 | |
| Domain | KA1_dom | 6.99e-05 | 5 | 50 | 2 | IPR001772 | |
| Domain | - | 6.99e-05 | 5 | 50 | 2 | 1.20.1270.50 | |
| Domain | - | 6.99e-05 | 5 | 50 | 2 | 3.20.110.10 | |
| Domain | Glyco_hydro_38_C | 6.99e-05 | 5 | 50 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 6.99e-05 | 5 | 50 | 2 | SM00872 | |
| Domain | Alpha-mann_mid | 6.99e-05 | 5 | 50 | 2 | PF09261 | |
| Domain | Glyco_hydro_38_N | 6.99e-05 | 5 | 50 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 6.99e-05 | 5 | 50 | 2 | IPR027291 | |
| Domain | KA1 | 6.99e-05 | 5 | 50 | 2 | PF02149 | |
| Domain | KA1 | 6.99e-05 | 5 | 50 | 2 | PS50032 | |
| Domain | - | 6.99e-05 | 5 | 50 | 2 | 3.30.310.80 | |
| Domain | Glyco_hydro_38_cen | 6.99e-05 | 5 | 50 | 2 | IPR015341 | |
| Domain | Glyco_hydro_57/38_cen | 6.99e-05 | 5 | 50 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38C | 6.99e-05 | 5 | 50 | 2 | PF07748 | |
| Domain | Glyco_hydro_38 | 6.99e-05 | 5 | 50 | 2 | PF01074 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 1.46e-04 | 7 | 50 | 2 | IPR011330 | |
| Domain | NAD_binding_6 | 1.46e-04 | 7 | 50 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 1.46e-04 | 7 | 50 | 2 | PF08022 | |
| Domain | KA1/Ssp2_C | 1.46e-04 | 7 | 50 | 2 | IPR028375 | |
| Domain | FAD-bd_8 | 1.46e-04 | 7 | 50 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 1.46e-04 | 7 | 50 | 2 | IPR013121 | |
| Domain | Haem_peroxidase | 3.12e-04 | 10 | 50 | 2 | IPR010255 | |
| Domain | An_peroxidase | 3.12e-04 | 10 | 50 | 2 | PF03098 | |
| Domain | PEROXIDASE_3 | 3.12e-04 | 10 | 50 | 2 | PS50292 | |
| Domain | Haem_peroxidase_animal | 3.12e-04 | 10 | 50 | 2 | IPR019791 | |
| Domain | - | 3.12e-04 | 10 | 50 | 2 | 1.10.640.10 | |
| Domain | Ferric_reduct | 4.56e-04 | 12 | 50 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 4.56e-04 | 12 | 50 | 2 | IPR013130 | |
| Domain | - | 6.26e-04 | 14 | 50 | 2 | 2.60.40.1180 | |
| Domain | Glyco_hydro_b | 7.21e-04 | 15 | 50 | 2 | IPR013780 | |
| Domain | Gal_mutarotase_SF_dom | 9.31e-04 | 17 | 50 | 2 | IPR011013 | |
| Domain | Fd_Rdtase_FAD-bd | 1.17e-03 | 19 | 50 | 2 | IPR017927 | |
| Domain | FAD_FR | 1.17e-03 | 19 | 50 | 2 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 1.17e-03 | 19 | 50 | 2 | IPR017938 | |
| Domain | UBA | 2.91e-03 | 30 | 50 | 2 | SM00165 | |
| Domain | UBA | 4.18e-03 | 36 | 50 | 2 | PF00627 | |
| Domain | UBA | 6.18e-03 | 44 | 50 | 2 | IPR015940 | |
| Domain | UBA | 7.03e-03 | 47 | 50 | 2 | PS50030 | |
| Pathway | REACTOME_THYROXINE_BIOSYNTHESIS | 2.39e-04 | 9 | 37 | 2 | MM14833 | |
| Pathway | REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY | 2.98e-04 | 10 | 37 | 2 | M27955 | |
| Pathway | REACTOME_THYROXINE_BIOSYNTHESIS | 2.98e-04 | 10 | 37 | 2 | M27120 | |
| Pathway | REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY | 5.13e-04 | 13 | 37 | 2 | MM15701 | |
| Pathway | KEGG_MEDICUS_REFERENCE_N_GLYCAN_BIOSYNTHESIS | 7.86e-04 | 16 | 37 | 2 | M47632 | |
| Pathway | REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 8.89e-04 | 17 | 37 | 2 | MM14829 | |
| Pathway | REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 9.99e-04 | 18 | 37 | 2 | M27118 | |
| Pubmed | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. | 2.03e-06 | 2 | 50 | 2 | 28633507 | |
| Pubmed | Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity. | 2.03e-06 | 2 | 50 | 2 | 15972824 | |
| Pubmed | Congenital Hypothyroidism due to Oligogenic Mutations in Two Sudanese Families. | 2.03e-06 | 2 | 50 | 2 | 30375286 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8524845 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25586178 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23362256 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19144650 | ||
| Pubmed | Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. | 2.03e-06 | 2 | 50 | 2 | 10806195 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 11514595 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 16111680 | ||
| Pubmed | Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling. | 2.03e-06 | 2 | 50 | 2 | 24161126 | |
| Pubmed | Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells. | 2.03e-06 | 2 | 50 | 2 | 22523549 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 11762710 | ||
| Pubmed | Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. | 2.03e-06 | 2 | 50 | 2 | 11822874 | |
| Pubmed | Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. | 2.03e-06 | 2 | 50 | 2 | 11753072 | |
| Pubmed | Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis. | 2.03e-06 | 2 | 50 | 2 | 23281318 | |
| Pubmed | Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. | 2.03e-06 | 2 | 50 | 2 | 18281478 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15062544 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 31706280 | ||
| Pubmed | N-Glycan structure analysis using lectins and an alpha-mannosidase activity assay. | 2.03e-06 | 2 | 50 | 2 | 17113875 | |
| Pubmed | Regulated hydrogen peroxide production by Duox in human airway epithelial cells. | 2.03e-06 | 2 | 50 | 2 | 15677770 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 11443211 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 10601291 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 18177232 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24128054 | ||
| Pubmed | Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. | 2.03e-06 | 2 | 50 | 2 | 11778047 | |
| Pubmed | Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. | 2.03e-06 | 2 | 50 | 2 | 12824283 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 16754854 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 21915726 | ||
| Pubmed | NADPH oxidase-dependent acid production in airway epithelial cells. | 6.07e-06 | 3 | 50 | 2 | 15210697 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 24164541 | ||
| Pubmed | DUOX enzyme activity promotes AKT signalling in prostate cancer cells. | 6.07e-06 | 3 | 50 | 2 | 23225414 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 9108484 | ||
| Pubmed | Association of duoxes with thyroid peroxidase and its regulation in thyrocytes. | 6.07e-06 | 3 | 50 | 2 | 19952225 | |
| Pubmed | Nox4 and Duox1/2 Mediate Redox Activation of Mesenchymal Cell Migration by PDGF. | 1.21e-05 | 4 | 50 | 2 | 27110716 | |
| Pubmed | The type of DUOX-dependent ROS production is dictated by defined sequences in DUOXA. | 1.21e-05 | 4 | 50 | 2 | 22814254 | |
| Pubmed | Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells. | 1.21e-05 | 4 | 50 | 2 | 19339556 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 16478776 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 34784249 | ||
| Pubmed | Identification of a novel partner of duox: EFP1, a thioredoxin-related protein. | 2.02e-05 | 5 | 50 | 2 | 15561711 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.48e-05 | 1105 | 50 | 9 | 35748872 | |
| Pubmed | Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease. | 3.03e-05 | 6 | 50 | 2 | 23666762 | |
| Pubmed | Gatm, a creatine synthesis enzyme, is imprinted in mouse placenta. | 3.03e-05 | 6 | 50 | 2 | 12671064 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 17332529 | ||
| Pubmed | APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury. | 3.03e-05 | 6 | 50 | 2 | 28165467 | |
| Pubmed | Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. | 4.23e-05 | 7 | 50 | 2 | 19005069 | |
| Pubmed | 5.88e-05 | 52 | 50 | 3 | 20114047 | ||
| Pubmed | CALCOCO2 EPPK1 ATP6V0D1 MAN2A1 NUDT21 FUBP1 MPZL1 IFI30 PPP1CB | 8.56e-05 | 1297 | 50 | 9 | 33545068 | |
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 18330979 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 16608528 | ||
| Pubmed | 9.05e-05 | 10 | 50 | 2 | 18314154 | ||
| Pubmed | HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments. | 9.05e-05 | 10 | 50 | 2 | 18215327 | |
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 30755476 | ||
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 28949961 | ||
| Pubmed | LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. | 2.10e-04 | 15 | 50 | 2 | 14976552 | |
| Pubmed | 2.10e-04 | 15 | 50 | 2 | 8892864 | ||
| Pubmed | 2.40e-04 | 16 | 50 | 2 | 14594945 | ||
| Pubmed | 2.72e-04 | 17 | 50 | 2 | 2355006 | ||
| Pubmed | 3.29e-04 | 417 | 50 | 5 | 19199708 | ||
| Pubmed | Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly. | 3.31e-04 | 93 | 50 | 3 | 38245532 | |
| Pubmed | 3.41e-04 | 19 | 50 | 2 | 19022256 | ||
| Pubmed | 3.79e-04 | 20 | 50 | 2 | 12560567 | ||
| Pubmed | 4.18e-04 | 21 | 50 | 2 | 25708312 | ||
| Pubmed | 4.59e-04 | 22 | 50 | 2 | 8673525 | ||
| Pubmed | Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation. | 4.59e-04 | 22 | 50 | 2 | 9109416 | |
| Pubmed | 4.59e-04 | 22 | 50 | 2 | 11530211 | ||
| Pubmed | 5.03e-04 | 23 | 50 | 2 | 1736542 | ||
| Pubmed | 5.03e-04 | 23 | 50 | 2 | 8093218 | ||
| Pubmed | Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins. | 5.03e-04 | 23 | 50 | 2 | 3099781 | |
| Pubmed | Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. | 5.03e-04 | 23 | 50 | 2 | 3264072 | |
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 5.95e-04 | 25 | 50 | 2 | 2283726 | |
| Pubmed | Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice. | 6.44e-04 | 26 | 50 | 2 | 33905568 | |
| Pubmed | 6.44e-04 | 26 | 50 | 2 | 8218172 | ||
| Pubmed | 8.59e-04 | 30 | 50 | 2 | 12676797 | ||
| Pubmed | 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. | 8.59e-04 | 30 | 50 | 2 | 16306228 | |
| Pubmed | STK11 is required for the normal program of ciliated cell differentiation in airways. | 9.17e-04 | 31 | 50 | 2 | 31636950 | |
| Pubmed | 9.96e-04 | 533 | 50 | 5 | 25544563 | ||
| Pubmed | Autophagosomal Content Profiling Reveals an LC3C-Dependent Piecemeal Mitophagy Pathway. | 1.04e-03 | 33 | 50 | 2 | 29149599 | |
| Pubmed | 1.24e-03 | 36 | 50 | 2 | 25063451 | ||
| Pubmed | 1.31e-03 | 37 | 50 | 2 | 2542563 | ||
| Pubmed | 1.31e-03 | 37 | 50 | 2 | 2541446 | ||
| Pubmed | 1.38e-03 | 38 | 50 | 2 | 2829950 | ||
| Pubmed | Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. | 1.38e-03 | 38 | 50 | 2 | 18267097 | |
| Pubmed | Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. | 1.38e-03 | 38 | 50 | 2 | 2187500 | |
| Cytoband | 15q15.3 | 3.43e-04 | 25 | 50 | 2 | 15q15.3 | |
| Cytoband | 20q11.22 | 7.56e-04 | 37 | 50 | 2 | 20q11.22 | |
| GeneFamily | Mannosidases alpha class 2 | 3.02e-05 | 5 | 32 | 2 | 1194 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-06 | 173 | 50 | 5 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 183 | 50 | 5 | 8d45dff06a199b1369576657f7f9dc0249c5f841 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 183 | 50 | 5 | 421265fa15d5a028cb567bb0904e670473ef102b | |
| ToppCell | Nasal_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.63e-06 | 195 | 50 | 5 | 7509b980b6b293df02bec619ef5b83a6c7b49c03 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.83e-06 | 198 | 50 | 5 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 172 | 50 | 4 | a7fd4d61fb5017dce001d69d6b9a01e6cdf58828 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 172 | 50 | 4 | 65b8935a972bf00b7a10dc2d442128fc0ed78bcb | |
| ToppCell | LPS-antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-05 | 178 | 50 | 4 | 289d1425c4e57fabcca994b27f9af1c0ce5d5bec | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 178 | 50 | 4 | b902059c3f861108fc64cbdc05e6f44378f5be2c | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.84e-05 | 179 | 50 | 4 | 7aa4137f672dadb3be92009cde6e0ea60a15372d | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.84e-05 | 179 | 50 | 4 | c7d7a66fca6a41de0af3cc2b75a29a54456842cd | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-05 | 180 | 50 | 4 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 187 | 50 | 4 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 187 | 50 | 4 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 187 | 50 | 4 | 8ff9f771d10c372d771c92dfa9006aa81aec4681 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 187 | 50 | 4 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.10e-05 | 190 | 50 | 4 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 191 | 50 | 4 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 191 | 50 | 4 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 191 | 50 | 4 | e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-05 | 193 | 50 | 4 | 33437fdb417d78463caee14a9f0e094da1733829 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(001)_CD16+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 6.61e-05 | 194 | 50 | 4 | 89cb262e04d7105012e957e0add44c73de6c1ed0 | |
| ToppCell | (0)_Myeloid-(001)_CD16+_Monocyte|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 6.61e-05 | 194 | 50 | 4 | 4240d0b3cf264f51dcf0cb4d0a18641d85d38638 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 195 | 50 | 4 | d7e92bcbd05b93e86a1e1397e44ad27a9e2e637a | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.74e-05 | 195 | 50 | 4 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 195 | 50 | 4 | 3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3 | |
| ToppCell | 3'-Airway_Nasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.74e-05 | 195 | 50 | 4 | 7ffbdbe95b248699bf6300322d084d21a4a4b1b8 | |
| ToppCell | (001)_CD16+_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 6.88e-05 | 196 | 50 | 4 | 33843d550cbca03c044d593b1f6972e4d3871f7f | |
| ToppCell | 3'-Airway_Nasal-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.88e-05 | 196 | 50 | 4 | eadc3e60104214cb5f6cfb098a5c5ea0f83d15bd | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.88e-05 | 196 | 50 | 4 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.01e-05 | 197 | 50 | 4 | 598fb7a9a8400af49d90807b3155d3cc1c34f505 | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.01e-05 | 197 | 50 | 4 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.01e-05 | 197 | 50 | 4 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 197 | 50 | 4 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.01e-05 | 197 | 50 | 4 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 7.15e-05 | 198 | 50 | 4 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.15e-05 | 198 | 50 | 4 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 7.15e-05 | 198 | 50 | 4 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 7.29e-05 | 199 | 50 | 4 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | critical-Epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.29e-05 | 199 | 50 | 4 | bbb44e2a52f102a6d891ead6c06d6c07221abd33 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.29e-05 | 199 | 50 | 4 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.29e-05 | 199 | 50 | 4 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.29e-05 | 199 | 50 | 4 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-05 | 199 | 50 | 4 | 7b3d4c62b11268c7c1599600d8a7b331287cf21a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.44e-05 | 200 | 50 | 4 | f386a86b127433cbac306950443355bd723080ff | |
| ToppCell | moderate-Epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.44e-05 | 200 | 50 | 4 | 095783c9b75113ae350c2d5fb1195d71b41fa695 | |
| ToppCell | NS-moderate-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.44e-05 | 200 | 50 | 4 | 85940b4bf7971b872469dea8b8d7a45bdeb2a909 | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 7.44e-05 | 200 | 50 | 4 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | Severe-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 7.44e-05 | 200 | 50 | 4 | 6ead9db88568bb829d564a6d8e85f71fd765bac0 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.44e-05 | 200 | 50 | 4 | 0cc7ff7b6a4eb05d2370ec2f3b9dbfe8cb0699de | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.44e-05 | 200 | 50 | 4 | b75154417c215b8853186bff46d624ebd387ac4f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.44e-05 | 200 | 50 | 4 | b9cede2e0939c6b60ce1aa16d7efaaae79354580 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.44e-05 | 200 | 50 | 4 | b762bf6f432eac05a476f6e2ab4da27dd13a2317 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.44e-05 | 200 | 50 | 4 | 4c63204e0d868dd4c11c1604a238624a3ad54485 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 200 | 50 | 4 | 133853d0f55c63ebe94dd54151f9f1f90650a0d8 | |
| ToppCell | Severe_COVID-19-Epithelial|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.44e-05 | 200 | 50 | 4 | 49910efb6d888c208cd50530b03af19f87070630 | |
| ToppCell | Severe-Epithelial-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 7.44e-05 | 200 | 50 | 4 | 3bd1ce2793651c9badd69f011d2531183594e5f4 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.24e-05 | 75 | 50 | 3 | 3167beedef7304697e9577270cdeacfc9743cee1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.24e-05 | 75 | 50 | 3 | 70c346f92a9ac7e33fc1b9dee1dca0bf9ae0a38c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.24e-05 | 75 | 50 | 3 | 26d6e54ed0a6c3ff57f6269c460177bc7b8bf979 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.37e-04 | 89 | 50 | 3 | 42432936a6b4289cc4b42fcb576fb09073f2264b | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.37e-04 | 89 | 50 | 3 | 6c594e13f169970b337c2fc3ab969faf6db1a27a | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 100 | 50 | 3 | 97ca9cda55a05fbb4d1f5d61f847c965e014f05c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-04 | 108 | 50 | 3 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-04 | 108 | 50 | 3 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.28e-04 | 131 | 50 | 3 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.37e-04 | 132 | 50 | 3 | 617644597726e881cd343e57f6edb5a98473b421 | |
| ToppCell | Mild/Remission-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.57e-04 | 134 | 50 | 3 | 5bd1e3fa6278facd9e949e9e5e244e700190126b | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.52e-04 | 143 | 50 | 3 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.52e-04 | 143 | 50 | 3 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | facs-Aorta-Heart-24m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 152 | 50 | 3 | 1da25f913b0fb167f66e539aef509ca44893a878 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_or_Epithelioid_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.60e-04 | 152 | 50 | 3 | 6f9c343669883618cd9c1c8921a90c34d153f303 | |
| ToppCell | facs-Aorta-Heart-24m-Mesenchymal-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 152 | 50 | 3 | 254f92d9e6c9c6404f3875dd54d655af87854b14 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 6.72e-04 | 153 | 50 | 3 | a156710217ef07c07a80ca6504fa0784d86380fa | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD4_TEM|Bac-SEP / Disease, Lineage and Cell Type | 7.11e-04 | 156 | 50 | 3 | ef6bad99bcb30956863cd490c613e251f3b27ba0 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.38e-04 | 158 | 50 | 3 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.51e-04 | 159 | 50 | 3 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-04 | 159 | 50 | 3 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.65e-04 | 160 | 50 | 3 | b4844a8c7755a2b2868019791d8d224154973445 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.65e-04 | 160 | 50 | 3 | 01ae730e9d0d05f3277f862f0c09bafb32b89db5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-04 | 160 | 50 | 3 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.65e-04 | 160 | 50 | 3 | 6de9e7be1d860d82d503bfbc779e72f072a6efc3 | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.79e-04 | 161 | 50 | 3 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.93e-04 | 162 | 50 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-04 | 162 | 50 | 3 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.22e-04 | 164 | 50 | 3 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.22e-04 | 164 | 50 | 3 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.22e-04 | 164 | 50 | 3 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.22e-04 | 164 | 50 | 3 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.22e-04 | 164 | 50 | 3 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.22e-04 | 164 | 50 | 3 | cfe07a1ebed8aecb08d0476db71fe314998d54aa | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.22e-04 | 164 | 50 | 3 | 6d331e74efecb4733d87653f86cd67247be05025 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.22e-04 | 164 | 50 | 3 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.36e-04 | 165 | 50 | 3 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.36e-04 | 165 | 50 | 3 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-plasma_cell-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.51e-04 | 166 | 50 | 3 | 139bf49eb3624d9eec7e8a2cb33d69716d63a7c5 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.51e-04 | 166 | 50 | 3 | 85f59c3cc7db8863ec0044f1fcc14580834f830b | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 166 | 50 | 3 | c0af93db981dfd448abc7efcd257f3e5ff066aae | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-04 | 168 | 50 | 3 | 41da200bbff5c663c39f67c38d6d5f43b0ad9494 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-CMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.81e-04 | 168 | 50 | 3 | e223bd7ae2a28c007e8b365f30d50d3bee83ba38 | |
| Disease | phenylketonuria (implicated_via_orthology) | 1.62e-05 | 4 | 49 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | visual impairment and progressive phthisis bulbi (implicated_via_orthology) | 1.62e-05 | 4 | 49 | 2 | DOID:0070356 (implicated_via_orthology) | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 9.65e-05 | 9 | 49 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | hypothyroidism (implicated_via_orthology) | 2.08e-04 | 13 | 49 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 2.43e-04 | 14 | 49 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | theta wave measurement | 3.62e-04 | 17 | 49 | 2 | EFO_0006873 | |
| Disease | Agouti-related protein measurement | 9.23e-04 | 27 | 49 | 2 | EFO_0008016 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.81e-03 | 145 | 49 | 3 | DOID:1289 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSYAIGKPGDLNQPY | 836 | Q5SY80 | |
| GLEGPGPKLYQHYQQ | 141 | Q7RTS1 | |
| LYLGGYPDYGAIPKA | 3796 | P98160 | |
| YPKLYLDGPFGEGHQ | 1361 | Q9NRD9 | |
| GEGPFRLSPYKPYNN | 471 | Q8N6Y1 | |
| PGNYGEKGNPYTKLE | 166 | Q3ZCV2 | |
| GAYLFLPDGNAKPYV | 806 | Q16706 | |
| GLDSYDYLQNAPPGF | 96 | Q9BUR5 | |
| NDYGYGGQKRPLEDG | 56 | Q96AE4 | |
| ADGLPPFNYSLGLYQ | 301 | Q96KR4 | |
| AGYPKLYLDGPFGEG | 1356 | Q9NRD8 | |
| FGGLPEFYNIPQGYT | 346 | Q9BV94 | |
| AGADGYGYLAPPKYL | 181 | P58012 | |
| LGYKEPLGNIDFYPN | 211 | Q8WWY8 | |
| LGQLTGGYKPNPQIY | 156 | P00973 | |
| GGPGPDYYLKNYEDD | 136 | Q8WWQ2 | |
| SQGQVYLGNYPPFKD | 91 | O95297 | |
| AGGQFLAPPGAYYQQ | 276 | Q96IR7 | |
| KFPPCEEYLQGGYLG | 16 | P09016 | |
| EYGGFPPEANYLFLG | 76 | P62140 | |
| IGPKFGYDEIDNGYL | 226 | Q15067 | |
| YYGLPDGAGDLLPDK | 296 | Q8WZ55 | |
| GNGPPVNYKTGNLYL | 36 | P13284 | |
| LGEGPNNGYFDKLPY | 271 | Q9UKA2 | |
| PPGLYRANLGKLGAY | 406 | Q9BQN1 | |
| NQLGLYPYFGPRGTA | 76 | O43820 | |
| APKYGRGQLNYPLPD | 346 | Q7Z591 | |
| NPGLAYGNPYSGIQE | 371 | Q13137 | |
| PGGLTGPLNYYRNLF | 271 | Q9H6B9 | |
| SGAYLFLPDGEAKPY | 811 | P49641 | |
| PYAAPELFQGKKYDG | 221 | Q9P0L2 | |
| YAAPELFQGKKYDGP | 221 | Q96L34 | |
| APLFELYDNAPGYGP | 196 | O43809 | |
| NDYQGPGGLLDYIDK | 466 | Q92503 | |
| ENYGGNFPLYLTKLP | 31 | O75309 | |
| AGYNKFLRPNFGGEP | 46 | O00591 | |
| IAPQGLQGGFAPDYY | 356 | O60478 | |
| EKQPAPGDAYGDAGY | 241 | P08247 | |
| GGLPDLDIYLYNKPG | 2271 | Q5T011 | |
| AAGLGYDPYNPELPK | 51 | Q8N1G1 | |
| PLYPKGGEKLQFDYG | 411 | Q9P2Y5 | |
| QEGPLALYKGLGPAY | 261 | Q6PIV7 | |
| GYPDPYGGEKLALFQ | 121 | P58107 | |
| AGGPEGKDYCILYNP | 36 | Q8TCT7 | |
| NGVYLNPAPGQDYLL | 2021 | O00507 | |
| PLGPIKAENDYGAYL | 321 | A1YPR0 | |
| NPYADSLGKPDYPGA | 196 | Q6UXY8 | |
| FGPPNTLYEGGYFKA | 46 | Q712K3 | |
| GLPFIGAKLQYGDPY | 811 | Q9H9Y6 | |
| GKYLNEYNGSYIPPG | 141 | Q8IWU6 | |
| YPEYKLLFEGAGSNP | 271 | P61421 |